newsfilter
← Latest News
PR Newswire·

Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

RED BANK, N.J., March 13, 2023 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced it has cancelled the